⌘K

Login Start Free

Home/Filings/4/0001000229-19-000045

4//SEC Filing

van Kempen Margaret Ann 4

Accession 0001000229-19-000045

CIK 0001000229other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:05 PM ET

Size

14.9 KB

Accession

0001000229-19-000045

Insider Transaction Report

Form 4

Period: 2019-04-01

CORE LABORATORIES N VCLB

van Kempen Margaret Ann

Director

Transactions

Exercise/Conversion
Common Shares
2019-04-01+1,335→ 4,428 total
Tax Payment
Common Shares
2019-04-01$68.93/sh−695$47,906→ 3,733 total
Exercise/Conversion
Common Shares
2019-04-01+1,387→ 5,120 total
Award
Restricted Shares
2019-04-01+2,177→ 2,177 total
Exercise: $0.00→ Common Shares (2,177 underlying)
Exercise/Conversion
Restricted Shares
2019-04-01−1,387→ 0 total
Exercise: $0.00→ Common Shares (1,387 underlying)
Exercise/Conversion
Restricted Shares
2019-04-01−1,335→ 0 total
Exercise: $0.00→ Common Shares (1,335 underlying)
Tax Payment
Common Shares
2019-04-01$68.93/sh−722$49,767→ 4,398 total

Footnotes (3)

[F1]The Restricted Shares vested at the end of a three-year vesting period ending April 1, 2019.
[F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2019.
[F3]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2020, subject to the terms of issuance.

Documents

1 file

4
wf-form4_155423552450834.xmlPrimary
FORM 4

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1

filerCIK 0001550876

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 4:05 PM ET
Size: 14.9 KB

View on SEC.gov